B Cell News and Research

RSS

Innovative therapy targets and destroys leukemia stem cells

Scientists at City of Hope, one of the largest cancer research and treatment organizations in the United States, have devised an innovative approach to target and destroy hard-to-kill leukemia stem cells.

26 Feb 2024

Breakthrough research unveils β-cell dynamics in Type 1 diabetes

About eight million people live with Type 1 diabetes (T1D) worldwide, a chronic autoimmune condition in which the body attacks and destroys its own insulin-producing β-cells (pronounced "beta") in the pancreas, leading to a lack of insulin and inability to regulate blood sugar.

26 Feb 2024

Gut bacteria may be responsible for sight loss in certain inherited eye diseases

Sight loss in certain inherited eye diseases may be caused by gut bacteria, and is potentially treatable by antimicrobials, finds a new study in mice co-led by a UCL and Moorfields researcher.

26 Feb 2024

Understanding obesity's effects on liver metabolism

Your liver plays a vital role in your metabolism, the biological process which converts food into energy.

26 Feb 2024

Insights into gut plasticity mechanisms unveiled through fruit fly research

One of the most striking examples of gut plasticity can be observed in animals that are exposed to prolonged periods of fasting, such as hibernating animals or phyton snakes that goes for months without eating, where the gut shrinks with as much as 50%, but recovers in size following a few days of re-feeding.

26 Feb 2024

Revolutionary stem cell culture method produces full model of human central nervous system

The first stem cell culture method that produces a full model of the early stages of the human central nervous system has been developed by a team of engineers and biologists at the University of Michigan, the Weizmann Institute of Science, and the University of Pennsylvania.

26 Feb 2024

Structural study identifies target for broad-spectrum antivirals against herpesviruses

Human herpesviruses comprise the alpha, beta, and gamma subfamilies and are a widely prevalent group of DNA-enveloped viruses, capable of establishing lifelong latent infections in humans and causing various diseases.

26 Feb 2024

Study: Antibody combination shows safety and anti-tumor activity in advanced cancer patients

In an early phase clinical trial, a combination of antibody-based medications targeting the immune system generated promising safety data and anti-tumor activity in individuals with various types of advanced cancer.

26 Feb 2024

Study reveals how long COVID can affect brain function through vascular disruption

The neurological response to coronavirus disease 2019 (COVID-19) may be due to brain-brain barrier (BBB) disruption.

26 Feb 2024

SARS-CoV-2-infection and vaccine-induced antibodies wane initially but stabilize for lasting protection

A study published in Immunity shows that antibody responses to SARS-CoV-2 infection and vaccination are long-lasting, with an initial decline followed by stabilization after seven to nine months, highlighting the effectiveness of mRNA vaccines and the importance of hybrid immunity.

25 Feb 2024

Mediterranean diet linked to lower depression risk in older women

A study in the British Journal of Nutrition finds that adherence to the Mediterranean diet is inversely associated with depressive symptoms, particularly in older women, highlighting the diet's potential mental health benefits.

25 Feb 2024

Researchers identify new therapeutic for patients with a rare autoimmune disease EGPA

An international team, including researchers from McMaster University and St. Joseph's Healthcare Hamilton, has identified a new therapeutic for patients with a rare autoimmune disease called eosinophilic granulomatosis with polyangiitis (EGPA).

24 Feb 2024

Researchers develop promising recombinant flu vaccine using nanoliposome technology

Recombinant protein vaccines, like the Novavax vaccine used to fight COVID-19, offer several advantages over conventional vaccines.

24 Feb 2024

Next-gen implants could be powered by dual-energy harvesting technology

Implantable biomedical devices - like pacemakers, insulin pumps and neurostimulators - are becoming smaller and utilizing wireless technology, but hurdles remain for powering the next-generation implants.

24 Feb 2024

Identifying antiviral protein IFN-γ as a potential biomarker for Long COVID

SARS-CoV-2 triggers the production of the antiviral protein IFN-γ, which is associated with fatigue, muscle ache and depression. New research shows that in Long COVID patients, IFN-y production persists until symptoms improve, highlighting a potential biomarker and a target for therapies.

24 Feb 2024

B Cell News and Research

Innovative therapy targets and destroys leukemia stem cells

Breakthrough research unveils β-cell dynamics in Type 1 diabetes

Gut bacteria may be responsible for sight loss in certain inherited eye diseases

Understanding obesity's effects on liver metabolism

Insights into gut plasticity mechanisms unveiled through fruit fly research

Revolutionary stem cell culture method produces full model of human central nervous system

Structural study identifies target for broad-spectrum antivirals against herpesviruses

Study: Antibody combination shows safety and anti-tumor activity in advanced cancer patients

Study reveals how long COVID can affect brain function through vascular disruption

SARS-CoV-2-infection and vaccine-induced antibodies wane initially but stabilize for lasting protection

Mediterranean diet linked to lower depression risk in older women

Researchers identify new therapeutic for patients with a rare autoimmune disease EGPA

Researchers develop promising recombinant flu vaccine using nanoliposome technology

Next-gen implants could be powered by dual-energy harvesting technology

Identifying antiviral protein IFN-γ as a potential biomarker for Long COVID

Decoding how bats distinguish sounds for navigation and communication

Understanding the role played by HIV in pulmonary hypertension

Novel approach uses patient's cells as "trojan horse" to target lung cancer cells

Gut microbial metabolite plays a role in exacerbating thrombosis

Genetic signature may help predict disease-free survival in patients with non-small cell lung cancer

Industry focus eBook - Cell and gene therapy (2nd edition) eBook

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

Latest News